Cancer Gone: Virtual Parliamentary Event to Explore Cancer Research and Innovation

OTTAWA, April 29, 2021 Research Canada and the Parliamentary Health Research Caucus, in collaboration with co-host the Canadian Cancer Society, are proud to host a virtual invitation-only reception with Parliamentarians to learn about the incredible advancements that have been made as a result of Canadian cancer research and innovation.

Canada has been a major research contributor, and thanks to Canadian discoveries made in collaboration with others around the world, we have an improved understanding of what causes cancer, how it develops, how best to treat it and how we can improve the quality of life of people living with cancer, which has been translated into new therapies and diagnostics.

This virtual reception, sponsored by Gilead Sciences Inc. and their company Kite Pharma, will feature 22 experts who will share research and innovations in the areas of early cancer detection at initial diagnosis and prior to progression and relapsethe role of precision medicine and immunotherapy in cancer researchpediatric and adolescent cancers, and cancer prevention. Some of Canada’s best and brightest scientists will present across four virtual panels, held in rooms sponsored by BioCanRxIMV Inc.Canadian Nuclear Laboratories, and AstraZeneca Canada, followed by a Q&A.

Date: Thursday, April 29, 2021 from 4:00 – 5:30 PM ET
Social media: #HealthResearchCaucus #cancerresearch

BioCanRx Room – Panel 1

Moderated by:
Rosie Goldstein, MD, FRCPC
McGill University

Jean-François Côté, PhD
Montreal Clinical Research Institute (IRCM)
Michel Duval, MD
CHU Sainte-Justine
Tony Eskander, MD, ScM, FRCSC
University of Toronto | Sunnybrook Health Sciences Center and Research Institute | ICES
Tara Horrill, PhD, RN
University of Manitoba
Sangeeta Murugkar, PhD
Carleton University

IMV Inc. Room – Panel 2

Moderated by:
Robert McMaster, PhD
Vancouver Coastal Health Research Institute | University of British Columbia

Rama Khokha, PhD, FRSC
Princess Margaret Cancer Centre | University of Toronto
David Malkin, MD, FRCPC
The Hospital for Sick Children
Christopher Ong, PhD
Vancouver Coastal Health Research Institute | University of British Columbia
David Palma, MD, PhD
Western University | London Health Sciences Centre
Chun Peng, PhD
York University
Yves St-Pierre, PhD
Institut national de la recherche scientifique

Moderated by:
Ryan Clarke
Canadian Nuclear Laboratories

Edouard Azzam, PhD
Canadian Nuclear Laboratories
Lieven Billen, PhD
Gilead Sciences Canada Inc.
Steven Narod, MD, PhD (hon), FRCPC, FRSC, CAHS
Women’s College Hospital | Women’s College Research Institute
Patricia Tonin, PhD
McGill University
Robin Urquhart, PhD
Dalhousie University | Nova Scotia Health
Franco Vizeacoumar, PhD
University of Saskatchewan

AstraZeneca Canada Room – Panel 4

Moderated by:
Isabelle Gagnon
AstraZeneca Canada

John Bell, PhD, FRSC
Ottawa Hospital Research Institute | BioCanRx | University of Ottawa
David Berman, MD, PhD
Queen’s University
Rebecca Deyell, MD, FRCPC
University of British Columbia | BC Children’s Hospital
Christine Friedenreich, PhD, FCAHS, FRSC
University of Calgary | Alberta Health Services
Jennifer Knox, MD, MSc, FRCPC
University of Toronto | Princess Margaret Cancer Centre

Parliamentary Health Research Caucus
Chair: Lloyd Longfield, MP (Guelph)
Vice-Chairs: Tamara Jansen, MP (Cloverdale—Langley City), Carol Hughes, MP (Algoma—Manitoulin—Kapuskasing)
Senate Representative: The Honourable Judith Seidman

Research Canada
Rosie Goldstein, MD, Chair
Deborah Gordon-El-Bihbety, President and CEO

About Research Canada
Research Canada is a national alliance dedicated to increasing investments in health research through collaborative advocacy and engaging government, academia, industry and non-profit sectors to build support for long-term health research funding. For more information, visit

Since 2009, Parliamentary Health Research Caucus events on Parliament Hill have helped to educate politicians on the social and economic benefits of Canadian health research and innovation, as well as introduce them to the multi-sector partnerships among academic, private sector and health charity stakeholders essential to a robust health research enterprise and innovation system.

– 30 –

For inquiries:
Christie Tomkins
Manager of Policy and Public Affairs